title: Reply to the comment by Ilhan et al. on our paper entitled 'effect of macular ischemia on intravitreal ranibizumab treatment for diabetic macular edema'.
authors.affiliation: 2nd Department of Ophthalmology, Ophthalmiatreion Athinon Eye Hospital, Athens, Greece.
authors.forename: Irini
authors.initials: I
authors.lastname: Chatziralli
authors.forename: Maria
authors.initials: M
authors.lastname: Douvali
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Theodossiadis
authors.forename: Alexandros A
authors.initials: AA
authors.lastname: Rouvas
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007511:Ischemia / Q000503:physiopathology*; D008269:Macular Edema / Q000188:drug therapy*; D008297:Male; D012171:Retinal Vessels / Q000502:physiology*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized